Skip to content

AirSculpt Technologies, Inc. AIRS Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Eli Lilly logo
Eli LillyLLY

Other financials

Income statement

See full
Revenue$39.4M0.0%
Gross profit$23.8M+1.6%
Operating income-$1.8M-13.4%
Net income-$2.4M+15.8%
EPS (diluted)-$0.03+40.0%

Balance sheet

See full
Cash & equivalents$16.7M+201%
Total debt$71.0M-27.1%
Total equity$100.3M+31.5%
Total assets$192.0M-5.5%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$51.0K-97.3%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$311.81M+4.7%
Enterprise value$366.14M-6.0%
P/S2.1×+0.3×

Profitability

See full
Gross margin59.6%-0.3pp
Operating margin-7.8%-0.4pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.6×
Current ratio0.7×+0.2×

Where this comes from

Reported directly by AirSculpt Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: AirSculpt Technologies, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AirSculpt Technologies, Inc.'s accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AirSculpt Technologies, Inc.'s accrued manufacturing costs?
AirSculpt Technologies, Inc. (AIRS) reported accrued manufacturing costs of $2.65M in Q1 2026.
How has AirSculpt Technologies, Inc.'s accrued manufacturing costs changed year-over-year?
AirSculpt Technologies, Inc.'s accrued manufacturing costs increased by 18.7% year-over-year, from $2.23M to $2.65M.
What is the long-term trend for AirSculpt Technologies, Inc.'s accrued manufacturing costs?
Over 5 years (2020 to 2025), AirSculpt Technologies, Inc.'s accrued manufacturing costs has grown at a 15.7% compound annual growth rate (CAGR), from $1.26M to $2.61M.